Pallister-hall syndrome

From WikiMD's Wellness Encyclopedia

Pallister-Hall syndrome

Pallister-Hall syndrome (PHS) is a rare genetic disorder characterized by a wide range of symptoms and physical abnormalities. It is caused by mutations in the GLI3 gene, which plays a crucial role in the development of various body systems during embryonic growth.

Signs and Symptoms[edit | edit source]

Individuals with Pallister-Hall syndrome may exhibit a variety of symptoms, including:

Genetics[edit | edit source]

Pallister-Hall syndrome is inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The GLI3 gene mutations responsible for PHS affect the Hedgehog signaling pathway, which is essential for proper embryonic development.

Diagnosis[edit | edit source]

Diagnosis of Pallister-Hall syndrome is based on clinical evaluation, identification of characteristic physical features, and genetic testing to confirm mutations in the GLI3 gene. Prenatal diagnosis is also possible through genetic testing if there is a known family history of the disorder.

Treatment[edit | edit source]

There is no cure for Pallister-Hall syndrome, and treatment is symptomatic and supportive. Management may involve:

Prognosis[edit | edit source]

The prognosis for individuals with Pallister-Hall syndrome varies widely depending on the severity of symptoms and the presence of complications. With appropriate medical care and support, many individuals can lead relatively normal lives.

Related Pages[edit | edit source]

Contributors: Prab R. Tumpati, MD